BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2014540)

  • 1. Early induction of immune resistance against leukemia in mice after lethal irradiation followed by syngeneic bone marrow transplantation and injection of syngeneic leukocytes.
    Skórski T; Kawalec M; Kawiak J
    Transplantation; 1991 Apr; 51(4):843-7. PubMed ID: 2014540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
    Skórski T; Kawalec M
    Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
    Skórski T; Kawalec M
    Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice.
    Skorski T; Kawalec M; Kawiak J
    Bone Marrow Transplant; 1990 Jan; 5(1):23-7. PubMed ID: 2297588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
    Skórski T; Ratajczak MZ; Kawalec M; Kawiak J
    Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
    Kawalec M; Skórski T; Kawiak J
    Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.
    Skórski T; Kawalec M; Kawiak J
    Cancer Immunol Immunother; 1990; 32(1):71-4. PubMed ID: 2289201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of immunologic and hematologic recovery in mice after lethal total body irradiation and reconstitution with syngeneic bone marrow cells treated or untreated with mafosfamide (ASTA Z 7654).
    Skórski T; Kawalec M; Hoser G; Ratajczak M; Gnatowski B; Kawiak J
    Bone Marrow Transplant; 1988 Nov; 3(6):543-51. PubMed ID: 2905613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug.
    Skórski T; Kawalec M
    Invest New Drugs; 1987; 5(2):167-9. PubMed ID: 3654151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of syngeneic bone marrow incubated with leucocyte antibodies. I. Suppression of lymphatic leukemia of syngeneic donor mice.
    Thierfelder S; Rodt H; Netzel B
    Transplantation; 1977 Jun; 23(6):459-63. PubMed ID: 325714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
    Weiss L; Nusair S; Reich S; Sidi H; Slavin S
    Cancer Immunol Immunother; 1996 Oct; 43(2):103-8. PubMed ID: 8954144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice.
    Morton JI; Siegel BV
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2162-5. PubMed ID: 4601580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo radiosensitizing effects of recombinant interleukin 6 on radiation resistant BCL-1 B-lineage leukemia cells in a murine syngeneic bone marrow transplant model system.
    Waddick KG; Finnegan DM; Chelstrom LM; Uckun FM
    Leuk Lymphoma; 1995 Sep; 19(1-2):121-8. PubMed ID: 8574156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation.
    Sykes M; Bukhari Z; Sachs DH
    Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
    Kosmatopoulos K; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
    Hornung RL; Longo DL; Bowersox OC; Kwak LW
    J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.